- Home
- MRK vs NYMTN Comparison
MRK vs NYMTN Comparison
Compare MRK & NYMTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- NYMTN
- Stock Information
- Founded
- MRK 2000
- NYMTN N/A
- Country
- MRK United States
- NYMTN United States
- Employees
- MRK N/A
- NYMTN 70
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- NYMTN Real Estate Investment Trusts
- Sector
- MRK Health Care
- NYMTN Real Estate
- Exchange
- MRK Nasdaq
- NYMTN Nasdaq
- Market Cap
- MRK 198.5B
- NYMTN N/A
- IPO Year
- MRK N/A
- NYMTN N/A
- Fundamental
- Price
- MRK $81.81
- NYMTN $20.61
- Analyst Decision
- MRK Buy
- NYMTN
- Analyst Count
- MRK 15
- NYMTN 0
- Target Price
- MRK $113.71
- NYMTN N/A
- AVG Volume (30 Days)
- MRK 18.1M
- NYMTN N/A
- Earning Date
- MRK 07-29-2025
- NYMTN N/A
- Dividend Yield
- MRK 3.96%
- NYMTN N/A
- EPS Growth
- MRK 667.14
- NYMTN N/A
- EPS
- MRK 6.88
- NYMTN N/A
- Revenue
- MRK $63,922,000,000.00
- NYMTN N/A
- Revenue This Year
- MRK $2.42
- NYMTN N/A
- Revenue Next Year
- MRK $5.77
- NYMTN N/A
- P/E Ratio
- MRK $11.90
- NYMTN N/A
- Revenue Growth
- MRK 4.10
- NYMTN N/A
- 52 Week Low
- MRK $73.31
- NYMTN N/A
- 52 Week High
- MRK $129.93
- NYMTN N/A
- Technical
- Relative Strength Index (RSI)
- MRK 58.88
- NYMTN 24.31
- Support Level
- MRK $78.14
- NYMTN $21.28
- Resistance Level
- MRK $80.25
- NYMTN $21.50
- Average True Range (ATR)
- MRK 1.91
- NYMTN 0.26
- MACD
- MRK 0.11
- NYMTN -0.07
- Stochastic Oscillator
- MRK 78.89
- NYMTN 0.00
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About NYMTN New York Mortgage Trust Inc. 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.